Mathes Company’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Mathes Company's BCAT Position: Q1 2026 in Review
Mathes Company reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 21% in Q1 2026, selling an estimated $269K and leaving 68,250 shares worth $964K. The position accounts for 0.35% of the portfolio, ranked #56.
Mathes Company first reported a position in BCAT in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.66M in Q4 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Mathes Company held 68,250 shares of BlackRock Capital Allocation Term Trust worth $964K as of Q1 2026.
- Mathes Company sold 18,250 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $269K.
- BlackRock Capital Allocation Term Trust made up 0.35% of Mathes Company's portfolio in Q1 2026, its #56 holding.
- Mathes Company first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 22 quarters since.
- Mathes Company's BlackRock Capital Allocation Term Trust position peaked at $1.66M in Q4 2024.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.